Humana · Zepbound and Wegovy coverage

Does Humana cover Zepbound or Wegovy?

Last updated

Not for weight loss alone on Part D; Medicare's GLP-1 Bridge has a $50 copay.

If it is not covered: the lowest cash prices now

  • Without insurance: compounded tirzepatide on a monthly plan, not FDA-approved

    Collective

    $69/mo + $199/yr membership · about $86 a month over a year with the membership · first order: membership free for the first 21 days, never charged if you cancel before

  • Without insurance: compounded semaglutide on a monthly plan, not FDA-approved

    Collective

    $59/mo + $199/yr membership · about $76 a month over a year with the membership · first order: membership free for the first 21 days, never charged if you cancel before

Not for weight loss alone on Part D; Medicare's GLP-1 Bridge has a $50 copay. Humana says standard Medicare Part D plans, including its own, do not cover GLP-1s only for weight loss. In its words: "No. Standard Medicare Part D prescription drug plans don’t cover GLP-1 medications only for weight loss." (Humana Medicare resources, Does Medicare Cover GLP-1 Weight Loss Drugs?, humana.com, read Nov 17, 2026). From July 1, 2026, eligible Part D members (Humana's included) can get Wegovy or the Zepbound KwikPen for weight loss for a $50 copay per 30-day supply through the CMS Medicare GLP-1 Bridge. In its words: "Starting July 1, 2026, the Medicare GLP-1 Bridge program will give eligible Part D plan members access to Foundayo®, Wegovy® (injection or tablet), or Zepbound® (KwikPen®) weight loss medications for a $50 copayment for each 30-day supply." (Humana Medicare resources, Does Medicare Cover GLP-1 Weight Loss Drugs?, humana.com, Jul 1, 2026, read Nov 17, 2026). CMS runs the Bridge from July 1, 2026 to December 31, 2027, outside the Part D benefit, so Humana and other Part D sponsors do not have to opt in. In its words: "The Medicare GLP-1 Bridge is a short-term demonstration run by CMS that will provide eligible Medicare Part D beneficiaries with access to certain GLP-1 drugs between July 1, 2026, and December 31, 2027." (CMS, Medicare GLP-1 Bridge frequently asked questions, cms.gov, Jul 1, 2026, read Nov 17, 2026).

Questions

Humana, Zepbound and Wegovy: common questions

Does Humana cover Zepbound for weight loss?

Not for weight loss alone on Part D; Medicare's GLP-1 Bridge has a $50 copay. Humana says standard Medicare Part D plans, including its own, do not cover GLP-1s only for weight loss. In its words: "No. Standard Medicare Part D prescription drug plans don’t cover GLP-1 medications only for weight loss." (Humana Medicare resources, Does Medicare Cover GLP-1 Weight Loss Drugs?, humana.com, read Nov 17, 2026). From July 1, 2026, eligible Part D members (Humana's included) can get Wegovy or the Zepbound KwikPen for weight loss for a $50 copay per 30-day supply through the CMS Medicare GLP-1 Bridge. In its words: "Starting July 1, 2026, the Medicare GLP-1 Bridge program will give eligible Part D plan members access to Foundayo®, Wegovy® (injection or tablet), or Zepbound® (KwikPen®) weight loss medications for a $50 copayment for each 30-day supply." (Humana Medicare resources, Does Medicare Cover GLP-1 Weight Loss Drugs?, humana.com, Jul 1, 2026, read Nov 17, 2026). CMS runs the Bridge from July 1, 2026 to December 31, 2027, outside the Part D benefit, so Humana and other Part D sponsors do not have to opt in. In its words: "The Medicare GLP-1 Bridge is a short-term demonstration run by CMS that will provide eligible Medicare Part D beneficiaries with access to certain GLP-1 drugs between July 1, 2026, and December 31, 2027." (CMS, Medicare GLP-1 Bridge frequently asked questions, cms.gov, Jul 1, 2026, read Nov 17, 2026). Zepbound not covered: the cash price at your dose

Does Humana cover Wegovy for weight loss?

Not for weight loss alone on Part D; Medicare's GLP-1 Bridge has a $50 copay. Humana says standard Medicare Part D plans, including its own, do not cover GLP-1s only for weight loss. In its words: "No. Standard Medicare Part D prescription drug plans don’t cover GLP-1 medications only for weight loss." (Humana Medicare resources, Does Medicare Cover GLP-1 Weight Loss Drugs?, humana.com, read Nov 17, 2026). From July 1, 2026, eligible Part D members (Humana's included) can get Wegovy or the Zepbound KwikPen for weight loss for a $50 copay per 30-day supply through the CMS Medicare GLP-1 Bridge. In its words: "Starting July 1, 2026, the Medicare GLP-1 Bridge program will give eligible Part D plan members access to Foundayo®, Wegovy® (injection or tablet), or Zepbound® (KwikPen®) weight loss medications for a $50 copayment for each 30-day supply." (Humana Medicare resources, Does Medicare Cover GLP-1 Weight Loss Drugs?, humana.com, Jul 1, 2026, read Nov 17, 2026). CMS runs the Bridge from July 1, 2026 to December 31, 2027, outside the Part D benefit, so Humana and other Part D sponsors do not have to opt in. In its words: "The Medicare GLP-1 Bridge is a short-term demonstration run by CMS that will provide eligible Medicare Part D beneficiaries with access to certain GLP-1 drugs between July 1, 2026, and December 31, 2027." (CMS, Medicare GLP-1 Bridge frequently asked questions, cms.gov, Jul 1, 2026, read Nov 17, 2026). Wegovy not covered: the cash price at your dose

Does Humana cover Wegovy for heart disease?

Humana says Wegovy may be covered by Part D when prescribed for cardiovascular disease. In its words: "Drugs like Ozempic® and Wegovy® may be covered by Part D if prescribed for diabetes management or cardiovascular disease." (Humana Medicare resources, Does Medicare Cover GLP-1 Weight Loss Drugs?, humana.com, read Nov 17, 2026).

What do Zepbound and Wegovy cost if Humana does not cover them?

Zepbound costs $299/28 days at 2.5 mg and $449/28 days at 15 mg without insurance at Amazon Pharmacy and LillyDirect (Eli Lilly), checked Nov 11, 2026 on pharmacy.amazon.com and zepbound.lilly.com. At 15 mg, the terms: at Amazon Pharmacy, through Dec 31, 2026, with Lilly's self-pay card, whose terms on Lilly's Zepbound savings page say "Card expires and savings end on 12/31/2026" and require each refill within 45 days of the previous delivery, or Lilly's regular $699 applies; at LillyDirect (Eli Lilly), Self Pay Journey price with a refill within 45 days; otherwise $499 at 7.5 mg or $699 at 10 to 15 mg. Wegovy costs $199/28 days, through Dec 31, 2026 at 0.25 mg and $349/28 days at 2.4 mg without insurance at Amazon Pharmacy and NovoCare (Novo Nordisk), checked Nov 11, 2026 on pharmacy.amazon.com and novocare.com. Compounded, not FDA-approved: compounded tirzepatide from $69/mo + $199/yr membership at Collective (about $86 a month over a year with the membership); compounded semaglutide from $59/mo + $199/yr membership at Collective (about $76 a month over a year with the membership). Every GLP-1's cash price without insurance

Does Medicaid cover Zepbound or Wegovy?

It depends on the state: 10 state programs cover GLP-1s for weight loss, by KFF's January 2026 map and the states' own notices since. Every state's Medicaid answer

GLPcompare links out only to sellers with a referral program: if you sign up or buy through one of those links, we may earn a commission at no extra cost to you. For other sellers we show the price and the seller's address, and suggest sellers we can link to. It never changes the price you pay or the underlying data. Our default order is lowest price first, with sellers that pay us moved up, and the note under each list says which order it shows; every lowest-cost sort uses the price alone. In a price table, a partner's offer says so in its terms. The order is not a medical recommendation; a higher-placed offer is not necessarily the lowest price or the right product for you.

What a plan covers is decided by the plan and the employer or program behind it, and changes; check your own plan's drug list before you rely on this. This page reports the insurer's own published words and sellers' own prices, not insurance or medical advice. Compounded medications are not FDA-approved. GLPcompare is an informational data platform, not a medical provider or pharmacy. Nothing here is medical advice, a diagnosis, or a recommendation to start, stop, or change any treatment. Data is aggregated from public sources and can be incomplete or out of date. Always confirm with a licensed clinician and the current FDA label.